Stentys appoints Michael D. Lesh, MD, as a Director

(PR-inside.com) http://www.stentys.com - Ronald Trahan Associates Inc. Ronald C. Trahan, APR, +1 508-359-4005 President Stentys (http://www.stentys.com) announced today that its Board of Directors has appointed Dr. Michael Lesh as a Director, effective immediately. Stentys is developing the world's first next-generation drug-eluting stent for treatment of blocked coronary artery bifurcations so that hundreds of thousands of patients might avoid open-chest surgery. Since 2004, Dr. Lesh has served as Chairman and CEO of Foster City, Calif.-based Evera Medical, one of four companies he has founded. His first venture, Atrionix, a developer of a novel ultrasound ablation catheter for atrial fibrillation, was acquired ..

More...